eISSN 2288-3657
pISSN 2288-3649
pISSN 2288-3649
The association of MTFR2 expression with clinicopathological characteristics of ESCC patients
| Characteristics | No. of cases | MTFR2 expression | χ2 test |
Fisher’s exact test |
|
|---|---|---|---|---|---|
| Low (%) | High (%) | ||||
| Sex | 0.351 | 0.267 | |||
| Female | 6 | 5 (83.33) | 1 (16.77) | ||
| Male | 109 | 72 (66.06) | 37 (33.94) | ||
| Age (yr) | 0.213 | 0.097 | |||
| ≤ 60 | 56 | 40 (71.43) | 16 (28.57) | ||
| > 60 | 59 | 37 (62.71) | 22 (37.29) | ||
| Clinical stage | < 0.001 | < 0.001 | |||
| I/II | 79 | 65 (82.29) | 14 (17.71) | ||
| III/IV | 36 | 12 (33.33) | 24 (66.67) | ||
| T stage | < 0.001 | < 0.001 | |||
| 1 | 20 | 17 (85.00) | 3 (15.00) | ||
| 2 | 36 | 27 (75.00) | 9 (25.00) | ||
| 3 | 40 | 27 (67.50) | 13 (32.50) | ||
| 4 | 19 | 6 (31.58) | 13 (68.42) | ||
| N stage | < 0.001 | < 0.001 | |||
| 0 | 76 | 60 (78.95) | 16 (21.05) | ||
| 1 | 33 | 16 (48.48) | 17 (51.52) | ||
| 2 | 6 | 1 (16.67) | 5 (83.33) | ||
| M stage | 0.040 | 0.037 | |||
| 0 | 110 | 76 (69.09) | 34 (30.91) | ||
| 1 | 5 | 1 (20.00) | 4 (80.00) | ||
| Histological differentiation | 0.029 | 0.015 | |||
| High | 22 | 17 (77.27) | 5 (22.73) | ||
| Moderate | 67 | 47 (70.15) | 20 (29.85) | ||
| Low | 26 | 13 (50.00) | 13 (50.00) | ||
J Cancer Prev 2021;26:250~257 https://doi.org/10.15430/JCP.2021.26.4.250
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd